Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Express Scripts
Colorcon
Merck
Moodys

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Litigation Details for Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc. (D. Del. 2015)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Janssen Pharmaceutica, N v. v. Mylan Pharmaceuticals, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-08-31 1 by Mylan of U.S. Patent Nos. 8,841,310 B2 ("the '310 Patent"), 7,125,879 B2 ("the &… '879 Patent") and 8,101,629 B2 ("the '629 Patent") (collectively, "the Patents-in-suit… Patents-in-suit") arising under the patent laws of the United States, 35 U.S.C. §§ 1 et seq. This…United States Patent and Trademark Office ("the PTO") issued the '310 Patent, entitled "…#39;310 Patent. 29. On October 24, 2006, the PTO issued the '879 Patent, entitled External link to document
2017-01-06 201 construction for a disputed term in U.S. Patent No. 8,101,629. Within five days the parties shall submit…PageID #: 5500 Plaintiffs own U.S. Patent 8,101,629 claiming the invention of a pharmaceutical…Plaintiffs filed this patent infringement suit. (D.I. 1). The '629 patent is one of eight asserted…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2017-11-09 258 United States Patent Nos. 8,841,310 (the '310 patent), 7,125,879 (the '879 patent), 8, 101,629… the '310 patent, the '879 patent, the '629 patent, the '551 patent, the '856… (the '629 patent), 8,080,551 (the '551 patent), 7,399,856 (the '856 patent), 7,563,922…the '922 patent), 8, 101, 752 (the '752 patent) and 8,618,291 (the '291 patent) (collectively…856 patent and the '922 patent. 5. Mylan and its officers, directors, employees, agents External link to document
2017-11-15 259 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,841,310 B2; 7,125,879 B2; 8,101,629…2015 9 November 2017 1:15-cv-00760 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.